Zephyrus Biosciences

About:

Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level.

Top Investors: Mission BioCapital, National Institutes of Health, SkyDeck Berkeley, Genoa Ventures, Life Science Angels

Description:

Zephyrus Biosciences provides research tools to enable protein analysis at the single-cell level. Addressing the burgeoning single-cell analysis market, our first product, the scWestern system, enables western blotting on individual cells for the first time. Researchers will utilize Zephyrus’s products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development. It was founded in 2013 and headquartered in Berkeley, California.

Total Funding Amount:

$1.86M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Berkeley, California, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)zephyrusbio.com

Founders:

Josh Molho, Kelly Gardner

Number of Employees:

1-10

Last Funding Date:

2017-06-01

IPO Status:

Private

Industries: